Purchases and Sales Made in Q1 2023 in Vir Biotechnology, Inc. (VIR)
This table provides information about the institutional ownership of Vir Biotechnology, Inc. (VIR) during Q1 2023. The information is specifically focused on institutions that hold shares of Vir Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-221K- 35.87% |
$4.93M - $6.83M
|
396K
$3.79M
|
|
|
May 15, 2023
Q1 2023
|
Capital Fund Management S.A.
Paris, I0 |
SELL
|
- |
-225K- 66.79% |
$5.01M - $6.94M
|
112K
$1.07M
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-579K- 49.16% |
$12.9M - $17.9M
|
599K
$5.73M
|
|
|
May 02, 2023
Q1 2023
|
Pacer Advisors, Inc.
Malvern, PA |
SELL
|
- |
-1.1M- 99.98% |
$24.5M - $33.9M
|
170
$1.63K
|
|
|
May 15, 2023
Q1 2023
|
Sb Investment Advisers (Uk) LTD
London, X0 |
SELL
|
- |
-1.94M- 9.57% |
$43.2M - $59.8M
|
18.3M
$175M
|